DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Grossberg GT, Manes F, Allegri RF. , et al.
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
CNS Drugs 2013;
27 (06) 469-478
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.